534 related articles for article (PubMed ID: 12823641)
1. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance.
Vgontzas AN; Bixler EO; Chrousos GP
J Intern Med; 2003 Jul; 254(1):32-44. PubMed ID: 12823641
[TBL] [Abstract][Full Text] [Related]
2. Sleep apnea is a manifestation of the metabolic syndrome.
Vgontzas AN; Bixler EO; Chrousos GP
Sleep Med Rev; 2005 Jun; 9(3):211-24. PubMed ID: 15893251
[TBL] [Abstract][Full Text] [Related]
3. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?
Vgontzas AN
Arch Physiol Biochem; 2008 Oct; 114(4):211-23. PubMed ID: 18946782
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance.
Vgontzas AN; Legro RS; Bixler EO; Grayev A; Kales A; Chrousos GP
J Clin Endocrinol Metab; 2001 Feb; 86(2):517-20. PubMed ID: 11158002
[TBL] [Abstract][Full Text] [Related]
5. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia.
Vgontzas AN; Papanicolaou DA; Bixler EO; Hopper K; Lotsikas A; Lin HM; Kales A; Chrousos GP
J Clin Endocrinol Metab; 2000 Mar; 85(3):1151-8. PubMed ID: 10720054
[TBL] [Abstract][Full Text] [Related]
6. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.
Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS
Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844
[TBL] [Abstract][Full Text] [Related]
7. Selective effects of CPAP on sleep apnoea-associated manifestations.
Vgontzas AN; Zoumakis E; Bixler EO; Lin HM; Collins B; Basta M; Pejovic S; Chrousos GP
Eur J Clin Invest; 2008 Aug; 38(8):585-95. PubMed ID: 18627419
[TBL] [Abstract][Full Text] [Related]
8. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome.
Tasali E; Van Cauter E; Ehrmann DA
J Clin Endocrinol Metab; 2006 Jan; 91(1):36-42. PubMed ID: 16219719
[TBL] [Abstract][Full Text] [Related]
9. Obstructive sleep apnoea and polycystic ovary syndrome: A comprehensive review of clinical interactions and underlying pathophysiology.
Kahal H; Kyrou I; Tahrani AA; Randeva HS
Clin Endocrinol (Oxf); 2017 Oct; 87(4):313-319. PubMed ID: 28640938
[TBL] [Abstract][Full Text] [Related]
10. Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome.
Chatterjee B; Suri J; Suri JC; Mittal P; Adhikari T
Sleep Med; 2014 Dec; 15(12):1547-53. PubMed ID: 25311833
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea.
Bonsignore MR; Esquinas C; Barceló A; Sanchez-de-la-Torre M; Paternó A; Duran-Cantolla J; Marín JM; Barbé F
Eur Respir J; 2012 May; 39(5):1136-43. PubMed ID: 22075482
[TBL] [Abstract][Full Text] [Related]
12. A Study to Evaluate the Effect of Body Mass Index on the Prevalence of Sleep-Disordered Breathing in Adult Patients with Metabolic Syndrome.
Sehgal IS; Dhooria S; Virdi S; Agarwal R; Chaudhry D
Indian J Chest Dis Allied Sci; 2016 Jul; 58(3):177-181. PubMed ID: 30152651
[TBL] [Abstract][Full Text] [Related]
13. Metabolic alterations in adolescents with obstructive sleep apnea.
Bhushan B; Ayub B; Loghmanee DA; Billings KR
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2368-73. PubMed ID: 26581829
[TBL] [Abstract][Full Text] [Related]
14. Obstructive sleep apnoea in obese adolescents and cardiometabolic risk markers.
Watson SE; Li Z; Tu W; Jalou H; Brubaker JL; Gupta S; Huber JN; Carroll A; Hannon TS
Pediatr Obes; 2014 Dec; 9(6):471-7. PubMed ID: 24106092
[TBL] [Abstract][Full Text] [Related]
15. Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females.
Kritikou I; Basta M; Vgontzas AN; Pejovic S; Liao D; Tsaoussoglou M; Bixler EO; Stefanakis Z; Chrousos GP
Eur Respir J; 2014 Jan; 43(1):145-55. PubMed ID: 23598957
[TBL] [Abstract][Full Text] [Related]
16. Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables.
Tassone F; Lanfranco F; Gianotti L; Pivetti S; Navone F; Rossetto R; Grottoli S; Gai V; Ghigo E; Maccario M
Clin Endocrinol (Oxf); 2003 Sep; 59(3):374-9. PubMed ID: 12919162
[TBL] [Abstract][Full Text] [Related]
17. Obesity-related sleepiness and fatigue: the role of the stress system and cytokines.
Vgontzas AN; Bixler EO; Chrousos GP
Ann N Y Acad Sci; 2006 Nov; 1083():329-44. PubMed ID: 17148748
[TBL] [Abstract][Full Text] [Related]
18. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state.
Gruber A; Horwood F; Sithole J; Ali NJ; Idris I
Cardiovasc Diabetol; 2006 Nov; 5():22. PubMed ID: 17078884
[TBL] [Abstract][Full Text] [Related]
19. Sleep-disordered breathing in obese children is associated with prevalent excessive daytime sleepiness, inflammation, and metabolic abnormalities.
Tsaoussoglou M; Bixler EO; Calhoun S; Chrousos GP; Sauder K; Vgontzas AN
J Clin Endocrinol Metab; 2010 Jan; 95(1):143-50. PubMed ID: 19926716
[TBL] [Abstract][Full Text] [Related]
20. Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome.
Nandalike K; Agarwal C; Strauss T; Coupey SM; Isasi CR; Sin S; Arens R
Sleep Med; 2012 Dec; 13(10):1307-12. PubMed ID: 22921588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
